| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A pandemic is no private matter: the COVID-19 vaccine mandate in Austria
|
Druml, Christiane
|
|
|
10 |
4 |
p. 322-324
|
article
|
| 2 |
Baricitinib for patients with severe COVID-19—time to change the standard of care?
|
Supady, Alexander
|
|
|
10 |
4 |
p. 314-315
|
article
|
| 3 |
Bringing biological ARDS phenotypes to the bedside with machine-learning-based classifiers
|
Whebell, Stephen
|
|
|
10 |
4 |
p. 319-320
|
article
|
| 4 |
Cardiorespiratory management of Duchenne muscular dystrophy: emerging therapies, neuromuscular genetics, and new clinical challenges
|
Birnkrant, David J
|
|
|
10 |
4 |
p. 403-420
|
article
|
| 5 |
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis
|
Lipworth, Brian
|
|
|
10 |
4 |
p. e38
|
article
|
| 6 |
Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis – Authors' reply
|
Lourijsen, Evelijn S
|
|
|
10 |
4 |
p. e39
|
article
|
| 7 |
Correction to Lancet Respir Med 2022; 10: 327–36
|
|
|
|
10 |
4 |
p. e43
|
article
|
| 8 |
COVID-19 vaccination in young children
|
Burki, Talha Khan
|
|
|
10 |
4 |
p. e41
|
article
|
| 9 |
Effects of SARS-CoV-2 on prenatal lung growth assessed by fetal MRI
|
Stoecklein, Sophia
|
|
|
10 |
4 |
p. e36-e37
|
article
|
| 10 |
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial
|
Ely, E Wesley
|
|
|
10 |
4 |
p. 327-336
|
article
|
| 11 |
Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial
|
Lourijsen, Evelijn S
|
|
|
10 |
4 |
p. 337-346
|
article
|
| 12 |
Epidemic thunderstorm asthma
|
Venkatesan, Priya
|
|
|
10 |
4 |
p. 325-326
|
article
|
| 13 |
Feasibility of lung cancer screening in resource-poor areas
|
The Lancet Respiratory Medicine,
|
|
|
10 |
4 |
p. 313
|
article
|
| 14 |
Long-term clinical outcomes of COVID-19 patients treated with imatinib
|
Duijvelaar, Erik
|
|
|
10 |
4 |
p. e34-e35
|
article
|
| 15 |
New guidelines for paediatric intensive care unit patients
|
Burki, Talha Khan
|
|
|
10 |
4 |
p. e42
|
article
|
| 16 |
One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study
|
Li, Ni
|
|
|
10 |
4 |
p. 378-391
|
article
|
| 17 |
One-off low-dose CT lung cancer screening in China: an appropriate strategy?
|
de Koning, Harry J
|
|
|
10 |
4 |
p. 320-322
|
article
|
| 18 |
Risk of serious COVID-19 outcomes among adults with asthma in Scotland: a national incident cohort study
|
Shi, Ting
|
|
|
10 |
4 |
p. 347-354
|
article
|
| 19 |
Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study
|
Izikson, Ruvim
|
|
|
10 |
4 |
p. 392-402
|
article
|
| 20 |
SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys
|
Chadeau-Hyam, Marc
|
|
|
10 |
4 |
p. 355-366
|
article
|
| 21 |
Surgery and uncontrolled chronic rhinosinusitis
|
Hopkins, Claire
|
|
|
10 |
4 |
p. 315-317
|
article
|
| 22 |
Tracing and vaccinating: how to REACT to COVID-19 pandemic
|
Castagnoli, Riccardo
|
|
|
10 |
4 |
p. 317-318
|
article
|
| 23 |
US EPA signals renewed regulatory scrutiny of toxic air pollution
|
Furlow, Bryant
|
|
|
10 |
4 |
p. e40
|
article
|
| 24 |
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis
|
Maddali, Manoj V
|
|
|
10 |
4 |
p. 367-377
|
article
|
Journal description